Muris C, Girard B, Creveuil C, et al: Management of premature rupture of membranes before 25 weeks. Eur J Obstet Gynecol Reprod Bioi 131(2):163, 2007
Miyakis S, Lockshin MD, Atsumi T, et al: International consensus statement on an update of the classiication criteria for definite anti phospholipid syndrome (APS). J hromb Haemost 4(2):295, 2006
Miyazaki K, Furuhashi M, Yoshida K, et al: Aggressive intervention of previable preterm premature rupture of membranes. Acta Obstet Gynecol Scand 91(8):923,r2012
Nadarajah R, Quek YS, Kuppannan K, et al: A randomised controlled trial of expectant management versus surgical evacuation of early pregnancy loss. Eur J Obstet Gynecol Reprod Bioi 178:35, 2014
Nahum GG: Uterine anomalies. How common are they, and what is their distribution among subtypes? J Reprod Med 43(10):877, 1998
Nakayama D, Masuzaki H, Miura K, et al: Efect of placenta previa on blood loss in second-trimester abortion by labor induction using gemeprost. Contraception 75(3):238, 2007
National Abortion Federation: 2016 Clinical policy guidelines. 2016. Available at: https://prochoice.org/wp-content/uploads/20 16-CPGs-web. pdf. Accessed April 23, 2017
Newmann SJ, Sokolof A, haryil M, et al: Same-day synthetic osmotic dilators compared with overnight laminaria before abortion at 14-18 weeks of gestation: a randomized controlled trial. Obstet Gynecol 123:271, 2014
Ngoc NT, Shochet T, Raghavan S, et al: Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion. Obstet Gynecol 118(3):601,r2011
Nielsen S, Hahlin M, Platz-Christensen J: Randomised trial comparing expectant with medical management for first trimester miscarriages. BJOG 106(8):804, 1999